Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia

Annals of Cardiac Anaesthesia

Volumn 12, Issue 1, 2009, Pages 4-9

  Landoni, Giovanni ^a,b,c   Bignami, Elena ^a,b   Oliviero, Fochi ^a,b   Zangrillo, Alberto ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NONE   (Italy)

Author keywords

Anaesthesia; Cardiac surgery; Desflurane; Isoflurane; Mortality; Sevoflurane; Volatile anaesthetics

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; INOTROPIC AGENT; ISOFLURANE; OXYGEN; PLACEBO; SEVOFLURANE; TROPONIN I;

ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; GENERAL ANESTHESIA; HALOGENATION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HOSPITALIZATION; HUMAN; INOTROPISM; INTENSIVE CARE UNIT; INTRAVENOUS ANESTHESIA; MEDICAL SOCIETY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; REVIEW; SURGICAL MORTALITY; SURGICAL RISK;

ANESTHETICS, INHALATION; CORONARY ARTERY BYPASS; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; METHYL ETHERS; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, OPERATIVE; TROPONIN I;

EID: 59949093292     PISSN: 09719784     EISSN: None     Source Type: Journal    
DOI: 10.4103/0971-9784.45006     Document Type: Review

References (27)

1. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007;50:1707-32.
2. Landoni G, Fochi O, Zangrillo A. Cardioprotection by volatile anesthetics in noncardiac surgery? No, not yet at least. J Am Coll Cardiol 2008;51:1321; author reply 1321-2.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
4. Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-65.
5. Cason BA, Gamperl AK, Slocum RE, Hickey RE Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocareial infarct size in rabbits. Anesthesiology 1997;87:1182-90.
6. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004;62:74-85.
7. De Hert SG. The concept of anaesthetic-induced cardioprotection: Clinical relevance. Best Pract Res Clin Anaesthesiol 2005; 19:445-59.
8. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100:11340-4.
9. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: A double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
10. Tritapepe L, Landoni G, Guarracino F, Pompei F, Crivellari M, Maselli D, et al. Cardiac protection by volatile anaesthetics: A multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007;24:323-31.
11. Guarracino F. Landoni G, Tritapepe L, Pompei F, Leoni A, Aletti G, et al. Myocardial damage prevented by volatile anesthetics: A multicenter randomized controlled study. J Cardiothorac Vasc Anesth 2006;20:477-83.
12. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
13. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310.
14. De Hert SG, Cromheecke S, ten Broecke PW, Mertens E, De Blier IG, Stockman BA, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003;99:314-23.
15. De Hert SG, ten Broecke PW, Mertens E, Van Sommeren EW, De Blier IG, Stockman BA, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
16. Tuman KJ, McCarthy RJ, Spiess BD, DaValle M, Dabir R, Ivankovich AD. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989:70:189-98.
17. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2006;20:493-502.
18. De Hert SG. Anesthetic preconditioning: how important is it in today's cardiac anesthesia? J Cardiothorac Vasc Anesth 2006;20:473-6.
19. Seccareccia F, Perucci CA, D'Errigo P, Arca M, Fusco D, Rosato S, et al. The Italian CABC Outcome Study: Short-term outcomes in patients with coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2006;29:56-62; discussion 62-4.
20. Bignami E, Landoni G, Fochi O, Calabro MG, Scandroglio AM, Mizzi A, et al. Volatile anesthetics reduce mortality in cardiac surgery: A meta regression on 34,310 italian patients. SMART. Milan, Italy. 2008 [abstr].
21. Landoni G, Biondi-Zoccai GG, Zangrillo A, Bignami E, D'Avolio S, Marchetti C, et al. Desflurane and sevoflurane in cardiac surgery: A meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2007;21:502-11.
22. Jakobsen CJ, Berg H, Hindsholm KB, Faddy N, Sloth E. The influence of propofol versus sevoflurane anesthesia on outcome in 10,535 cardiac surgical procedures. J Cardiothorac Vasc Anesth 2007;21:664-71.
23. Landoni G, Calabro MG, Marchetti C, Bignami E, Scandroglio AM, Dedola E, et al. Desflurane versus propofol in patients undergoing mitral valve surgery. J Cardiothorac Vasc Anesth 2007;21:672-7.
24. Cromheecke S, Pepermans V, Hendrickx E, Lorsomradee S, Ten Broecke PW, Stockman BA, et al. Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 2006; 103:289-96.
25. Landoni G, Zangrillo A, Fochi O, Maj G, Scandroglio AM, Morelli A, et al. Cardiac protection with volatile anesthetics in stenting procedures. J Cardiothorac Vasc Anesth 2008;22:543-7.
26. Fochi O, Bignami E, Landoni G, Pappalardo F, Calabrò MG, Giardina G, et al. Cardiac protection by volatile anesthetics in non-cardiac surgery: A meta-analysis. Minerva Anestesiol 2007;73:26.
27. Testa V, Bignami E, Tuoro A, Cavenago F, Garozzo FA, Poli D, et al. Sevoflurane versus Propofol in patients undergoing non-cardiac surgery: Is there any cardiac protection? SMART. Milan, Italy: 2008 [abstr].